PTC Therapeutics Inc
F:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
F:BH3
|
US |
|
B
|
Blue Label Telecoms Ltd
JSE:BLU
|
ZA |
|
Y
|
Yara International ASA
DUS:IU2
|
NO |
|
B
|
Bio-Techne Corp
XBER:TE1
|
US |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
|
N
|
Novavax Inc
F:NVV1
|
US |
|
Nexgen Energy Ltd
F:6NE
|
CA |
|
D
|
DoorDash Inc
F:DD2
|
US |
|
Service Properties Trust
NASDAQ:SVC
|
US |
|
T
|
Texas Instruments Inc
DUS:TII
|
US |
|
A
|
Aptiv PLC
XMUN:D7A
|
IE |
|
I
|
Intel Corp
XMUN:INL
|
US |
|
Kimberly-Clark de Mexico SAB de CV
OTC:KCDMF
|
MX |
|
M
|
MSCI Inc
XBER:3HM
|
US |
|
L
|
Live Nation Entertainment Inc
XBER:3LN
|
US |
|
K
|
Kimberly-Clark Corp
XMUN:KMY
|
US |
|
D
|
Deutsche Bank AG
BMV:DBN
|
DE |
|
H
|
HSBC Holdings PLC
F:HBC1
|
UK |
|
A
|
Amcor PLC
F:485
|
UK |
|
K
|
Kingspan Group PLC
DUS:KRX
|
IE |
Bankruptcy Probability
PTC Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PTC Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
6.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
434.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
222.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PTC Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PTC Therapeutics Inc has total debt of 2.5B USD. This includes both short-term (0 USD) and long-term (2.5B USD) debt.
You can find a full breakdown on its Balance Sheet.
